Key facts
- Synaptic Medical’s last known valuation is $46.0M (Jun 2011).
- It has raised $149.1M; the latest was Later Stage VC ($75.8M) in Oct 2025.
- Notable investors include Qiming Venture Partners, YuanBio Venture Capital, SIG (China), Huagai Capital, Medtronic — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Synaptic Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Synaptic Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synaptic Medical
Developer of a cardiac electrophysiology device designed to improve arrhythmia and related disease outcomes through safe and efficient procedures. The company offers user-friendly, comprehensive devices with intuitive design, integrated functionality, and advanced safety features, emphasizing simplicity, reliability, and holistic patient care, enabling cardiac electrophysiology teams to perform accurate arrhythmia diagnosis and treatment with greater confidence, reduce procedural complexity, and support improved long-term patient outcomes while fostering professional development and collaborative growth within clinical teams.
- Sector
- Healthcare
- HQ
- Carlsbad, CA, United States
- Founded
- 2005
- Employees
- 120
- Website
- synapticmed.com/
- Ownership
- Privately Held (backing)
Synaptic Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synaptic Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synaptic Medical in its N-PORT filings yet. We sweep new filings monthly.